Pegylated recombinant megakaryocyte growth and development factor. Hematopoietic

Drugs of the Future

Volumn 22, Issue 9, 1997, Pages 987-993

  De Boer, Richard H ^a   Basser, Russell L ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR;

CLINICAL TRIAL; DRUG ACTIVITY; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT NEOPLASTIC DISEASE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NONHUMAN; REVIEW; TOXICITY TESTING;

EID: 0030781318     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.09.421884     Document Type: Review

References (60)

1. Kaushansky, K., Broudy, V.C., Lin, N., Jorgensen, M.J., McCarty, J., Fox, N., Zucker-Franklin, D., Lofton-Day, C. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995, 92: 3234-8.
2. Hoffman, R., Yang, H.H., Bruno, E., Straneva, J.E. Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma. J Clin Invest 1985, 75: 1174-82.
3. Wendling, F., Varlet, P., Charon, M., Tambourin, P. MPLV: A retro-virus complex inducing an acute myeloproliferative leukemia disorder in adult mice. Virology 1986, 149: 242-6.
4. Souyri, M., Vigon, I., Penciolelli, J.F., Heard, J.M., Tambourin, P., Wendung, F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990, 63: 1137-47.
5. Vigon, I., Mornon, J.P., Cocault, L., Mitjavila, M.T., Tambourin, P., Gisselbrecht, S., Souyri, M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992, 89: 5640-4.
6. Methia, N., Louache, F., Vainchenker, W., Wendling, F. Oligodeoxynucleotides antisense to the protooncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993, 82: 1395-401.
7. Debili, N., Wendling, F., Cosman, D. et al. The Mpl receptor is expressed in megakaryocytic lineage from late progenitors to platelets. Blood 1995, 85: 391-401.
8. de Sauvage, F.J., Hass, P.E., Spencer, S.D. et al. Stimulation of megakaryopoiesis and thrombopoiesis by the c-mpl ligand. Nature 1994, 369: 533-8.
9. Bartley, T.D., Bogenberger, J., Hunt, P. et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 1994, 77: 1117-24.
10. Lok, S., Kaushansky, K., Holly, R.D. et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994, 369: 565-8.
11. Kuter, D.J., Beeler, D.L., Rosenberg, R.D. The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994, 91: 11104-8.
12. Kato, T., Ogami, K., Shimada, Y. et al. Purification and characterization of thrombopoietin. J Biochem (Tokyo) 1995, 118: 229-36.
13. Chang, M.D., McNinch, J., Basu, R. et al. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 1995, 270: 511-4.
14. Gurney, A.L., Kuang, W.-J., Xie, M.-H., Malloy, B.E., Eaton, D.L., de Sauvage, F.L. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 1995, 85: 981-8.
15. Ulich, T.R., Del Castillo, J., Yin, S. et al. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995, 86: 971-6.
16. Hokom, M.M., Lacey, D., Kinstler, O.B. et al. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood 1995, 86: 4486-92.
17. Kaushansky, K., Lok, S., Holly, R.D. et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994, 369: 568-71.
18. Zeigler, F.C., de Sauvage, F., Widmer, H.R., Keller, G.A., Donahue, C., Schreiber, R.D., Malloy, B., Hass, P., Eaton, D., Matthews, W. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994, 84: 4045-52.
19. Broudy, V.C., Lin, N.L., Kaushansky, K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995, 85: 1719-26.
20. Petzer, A.L., Zandstra, P.W., Piret, J.M., Eaves, C.J. Differential cytokine effects on primitive (CD34+ CD38-) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin. J Exp Med 1996, 183: 2551-8.
21. Kaushansky, K., Broudy, V.C., Grossmann, A., Humes, J., Lin, N., Ren, H.P., Bailey, M.C., Papayannopoulou, T., Forstrom, J.W., Sprugel, K.H. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 1995, 96: 1683-7.
22. Kobayashi, M., Laver, J.H., Kato, T., Miyazaki, H., Ogawa, M. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995, 86: 2494-9.
23. Broudy, V.C., Lin, N.L., Sabath, D.F. Human platelets display high-affinity receptors for thrombopoietin. Blood 1997, 89: 1896-904.
24. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P., Vainchenker, W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995, 86: 2516-25.
25. Hill, R.J., Leven, R.M., Levin, F.C., Levin, J. The effect of partially purified thrombopoietin on guinea pig megakaryocyte ploidy in vitro. Exp Hematol 1989, 17: 903-7.
26. + cells in a serum-free system. Brit J Haematol 1996, 93: 13-7.
27. Zucker-Franklin, D., Kaushansky, K. Effect of thrombopoietin on the development of megakaryocytes and platelets: An ultrastructural analysis. Blood 1996, 88: 1632-8.
28. Broudy, V.C., Lin, N.L., Fox, N., Taga, T., Saito, M., Kaushansky, K. Thrombopoietin stimulates colony-forming unit megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood 1996, 88: 2026-32.
29. Choi, E.S., Hokom, M., Bartley, T. et al. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells 1995, 13: 317-22.
30. Cramer, E.M., Norol, F., Guichard, J., Breton Gorius, J., Vainchenker, W., Masse, J.M., Debili, N. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997, 89: 2336-46.
31. Horie, K., Miyazaki, H., Hagiwara, T., Tahara, E., Matsumoto, A., Kadoya, T., Ogami, K., Kato, T. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Exp Hematol 1997, 25: 169-76.
32. de Sauvage, F.J., Carver-Moore, K., Luoh, S.-M., Ryan, A., Dowd, M., Eaton, D.L., Moore, M.W. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996, 183: 651-6.
33. Gurney, A.L., Carver-Moore, K., de Sauvage, F.J., Moore, M.A. Thrombocytopenia in c-mpl-deficient mice. Science 1994, 265: 1445-7.
34. Alexander, W.S., Roberts, A.W., Nicola, N.A., Li, R., Metcalf, D. Deficiencies in progenitor cells of multiple hemopoietic lineages and defective megakaryopoiesis in mice lacking the thrombopoietin receptor c-mpl. Blood 1996, 87: 2162-70.
35. Carver-Moore, K., Broxmeyer, H.E., Luoh, S.-M., Cooper, S., Peng, J., Burstein, S.A., Moore, M.W., de Sauvage, F.J. Low levels of erythroid and myeloid progenitors in thrombopoietin and c-mpl-deficient mice. Blood 1996, 88: 803-8.
36. Kuter, D.J., Rosenberg, R.D. Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood 1994, 84: 1464-72.
37. Wendling, F., Maraskovsky, E., Debill, N., Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D., Vainchenker, W. c-Mpl ligand is a humoral regulator of megakaryopoiesis. Nature 1994, 369: 571-4.
38. Kuter, D.J., Rosenberg, R.D. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995, 85: 2720-30.
39. Nichol, J.L., Hokom, M.M., Hornkohl, A. et al. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 1995, 95: 2973-8.
40. Farese, A.M., Hunt, P., Boone, T., MacVittie, T.J. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995, 86: 54-9.
41. Harker, L.A., Hunt, P., Marzec, U.M., Kelly, A.B., Tomer, A., Hanson, S.R., Stead, R.B. Regulation of platelet production and function by megakaryocyte growth and development factor (MGDF) in nonhuman primates. Blood 1996, 87: 1833-44.
42. Harker, L.A., Marzec, U.M., Hunt, P., Kelly, A.B., Tomer, A., Cheung, E., Hanson, S.R., Stead, R.B. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996, 88: 511-21.
43. Farese, A.M., Hunt, P., Grab, L.B., MacVittie, T.J. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 1996, 97: 2145-51.
44. Harker, L.A., Marzec, U.M., Kelly, A.B., Cheung, E., Tomer, A., Nichol, J.L., Hanson, S.R., Stead, R.B. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor. Blood 1997, 89: 155-65.
45. Molineux, G., Hartley, C., McElroy, P., McCrea, C., McNiece, I.K. Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood 1996, 88: 366-76.
46. Toombs, C.F., Young, C.H., Glaspy, J.A., Varnum, B.C. Megakaryocyte growth and development factor (MGDF) moderately enhances in-vitro platelet aggregation. Thromb Res 1995, 80: 23-33.
47. Montrucchio, G., Brizzi, M.F., Calosso, G., Marengo, S., Pegoraro, L., Camussi, G. Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood 1996, 87: 2762-8.
48. Rodríguez-Liñares, B., Watson, S.P. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J 1996, 316: 93-8.
49. Kubota, Y., Arai, T., Tanaka, T. et al. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation. Stem Cells 1996, 14: 439-44.
50. Oda, A., Miyakawa, Y., Druker, B.J. et al. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 1996, 87: 4664-70.
51. Yan, X.Q., Lacey, D., Fletcher, F. et al. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995, 86: 4025-33.
52. Zhou, W., Toombs, C.F., Zou, T., Guo, J., Robinson, M.O. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 1997, 89: 1551-9.
53. Sungaran, R., Markovic, B., Chong, B.H. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997, 89: 101-7.
54. de Boer, R.H., Roskos, L.K., Cheung, E., Fox, S., Basser, R.L., Marty, J. et al. Pharmacokinetic analysis of pegylated recombinant human megakaryocyte growth and development factor in humans. Blood 1997, submitted.
55. Basser, R.L, Rasko, J.E.J., Clarke, K. et al. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 1996, 348: 1279-81.
56. Rasko, J.E.J., Basser, R.L., Boyd, J. et al. Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Brit J Haematol 1997, 97: 871-80.
57. O'Malley, C.J., Rasko, J.E.J., Basser, R.L. et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996, 88: 3288-98.
58. Basser, R.L., Rasko, J.E.J., Clarke, K. et al. Randomised, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 1997, 89: 3118-28.
59. Morstyn, G., Campbell, L., Lieschke, G. et al. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 1989, 7: 1554-62.
60. Fanucchi, M., Glaspy, J., Crawford, J., Garst, J., Figlin, R., Sheridan, W., Menchaca, D., Tomita, Ozer, H., Harker, L. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New Engl J Med 1997, 336: 404-9.